) that were treated with LNA-antimiR-1246, LNA-antimiR-1290 or control. -tubulin was loaded as endogenous control. (f) The association between the intensity of MTs expression by IHC and status of regional lymph nodes (N) or distant metastasis (M) on a NSCLC tissue microarray. n=136. All error bars represent +SEM and statistical significance was calculated using Student's t-test (a,b,c,d) or Chi-squared test (f); *p<0.05, **p<0.01. Supplementary Fig. 9 . Expression levels of miR-1246 and miR-1290 across various human tumor types based on TCGA miRNA-Seq data. The plots showing the levels of miR-1246 (a) and miR-1290 (b) among up to 12 types of cancers relative to their normal tissues. pvalues were calculated using Student's t-test. Supplementary Table 1 (68) 46 (32) 23 (77) 7 (23) 74 (65) 39 (35) 0.279
Supplementary Tables
Histology (%) Adenocarcinoma Squamous cell carcinoma 97 (68) 46 (32) 11 (37) 19 (63) 87 (76) 27 (24) 0 33 (24) 71 (52) 16 (12) 16 (12) 9 (32) 18 (64) 0 (0) 1 (4) 24 (22) 53 (49) 16 (15) 15 (14) 0.031
104 (76) 32 (24) 27 (93) 2 (7) 77 (72) 30 (28) 0.024
132 (97) 4 (3) 29 (100) 0 (0) 103 (96) 4 (4) 0.578
81 (61) 24 (18) 23 (17) 5 (4) 27 (96) 0 (0) 1 (4) 0 (0) 54 (51) 24 (23) 22 (21) 5 (5) < 0.001
Poorly differentiated Undifferentiated 9 (6) 74 (53) 46 (33) 11 (8) 3 (10) 13 (43) 12 (40) 2 (7) 6 (5) 61 (55) 34 ( (46) 63 (44) 14 (10) 18 (60) 7 (23) 5 (17) 48 (42) 56 (50) 9 (8) 0.022 (61) 0 (0) 0 (0) 21 (20) 52 (50) 16 (15) 16 (15) 0.001
Supplementary
31 (97) 1 (3) 73 (70) 31 (30) 0.001
32 (100) 0 (0) 100 (96) 4 (4) 0.573 Serous  adenocarcinoma  3  II  T2N0M0  T  2  100  2  100   C6  Ovary  Adenocarcinoma  3  III  T3N0M0  T  2  100  2  90   C7   Pancreas Islet cell carcinoma  -T  3  100  3  100  C8  Pancreas Adenocarcinoma  3  II  T2N0M0  T  1  90  2  90  C9  Testis  Seminoma  -I  T1N0M0  T  3  100  3  100  D1  Testis  Embryonal carcinoma  -I  T2N0M0  T  3  100  1  65   D2  Thyroid  Medullary carcinoma  -II  T3N0M0  T  2 Note: N, normal; T, malignant tumor; NAT, cancer adjacent normal; n.a., not applicable; BT, benign tumor; Grade (1, well-differentiated; 2, moderately-differentiated; 3, poorly differentiated; 4, undifferentiated); TNM grading (T, primary tumor; N, regional lymph nodes; M, distant metastasis). Note: N, normal; T, malignant tumor; Mets, metastasis; Int., intensity; Pct., percentage; n.a., not applicable.

